Comparative Pharmacology
Head-to-head clinical analysis: AMINOSYN HF 8 versus AMINOSYN PF 10.
Peer-Reviewed Evidence
Head-to-head clinical analysis: AMINOSYN HF 8 versus AMINOSYN PF 10.
AMINOSYN-HF 8% vs AMINOSYN-PF 10%
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Aminosyn-HF 8% is a crystalline amino acid solution that provides essential and non-essential amino acids for protein synthesis, promoting nitrogen balance and tissue repair in patients unable to tolerate oral intake.
Aminosyn-PF 10% is a crystalline amino acid solution that provides essential and non-essential amino acids for protein synthesis and nitrogen balance in neonates and pediatric patients.
1-2 g/kg/day intravenously as total parenteral nutrition, typically administered as a continuous infusion over 24 hours.
Intravenous infusion: 1-1.5 g amino acids/kg/day (protein equivalent) as part of total parenteral nutrition. Typical rate: 0.5-2.0 mL/kg/hour initially, titrated to metabolic needs.
None Documented
None Documented
Not applicable as amino acids are rapidly cleared; terminal half-life of infused amino acids is approximately 10-30 minutes.
Variable; amino acids have half-lives of minutes to hours; clinical context: continuous infusion maintains steady state
Renal: >90% as amino acids and metabolites; fecal: <5%.
Renal: >90% as amino acids and metabolites; <10% fecal/biliary
Category C
Category C
Parenteral Nutrition Solution
Parenteral Nutrition Solution